台股 » 個股 » 大江 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

大江

(8436)
可現股當沖
  • 股價
    115.5
  • 漲跌
    ▲1.0
  • 漲幅
    +0.87%
  • 成交量
    194
  • 產業
    上櫃 生技醫療類股
  • 500人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
大江 (8436)籌碼相關-元大-沙鹿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-沙鹿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/221115.503115.00115.50-2183-1.09%
2025/01/152113.2500.00113.0021781.12%
2025/01/132118.501116.50116.0011730.58%
2025/01/100.1121.5000.00121.000.11690.06%
2025/01/090121.5000.00121.5001690.00%
2024/12/2000.000.4126.00125.00-0.4192-0.21%
2024/12/1800.002125.50125.00-2196-1.02%
2024/12/162125.0000.00125.0021981.01%
2024/12/1300.003123.17124.00-3199-1.51%
2024/12/0500.000.1127.50125.50-0.1200-0.05%
2024/11/2600.004125.50126.50-4211-1.89%
2024/11/2100.001124.00124.50-1215-0.46%
2024/11/201123.0000.00123.0012180.46%
2024/11/186122.7500.00123.0062242.67%
2024/11/151.1126.9000.00126.001.12240.50%
2024/11/131130.5000.00130.5012210.45%
2024/11/0500.001134.50134.00-1223-0.45%
2024/10/2400.0010136.50137.50-10254-3.92%
2024/10/185133.5000.00134.0052851.75%
2024/10/172134.0000.00134.0022900.69%
2024/10/161132.0000.00133.5012910.34%
2024/10/142132.0000.00133.5022990.67%
2024/09/300.1136.0000.00137.000.13390.03%
2024/09/201130.5000.00131.0013700.27%
2024/09/191132.0000.00133.0013660.27%
2024/09/1800.000132.50131.5003680.00%
2024/09/1100.001133.50131.00-1390-0.26%
2024/09/101131.5000.00132.0013900.26%
2024/08/2100.001141.50142.00-1400-0.25%
2024/08/161137.0000.00136.5013880.26%
2024/08/091140.0000.00136.0013810.26%
2024/08/0600.000.1134.00133.50-0.1384-0.02%
2024/08/0500.000.3134.00134.00-0.3377-0.09%
2024/07/3100.000144.50143.5003730.00%
2024/07/3000.000.8140.50142.00-0.8371-0.22%
2024/07/2200.001151.50151.50-1348-0.29%
2024/07/190.1151.5500.00151.000.13380.02%
2024/07/1800.001152.50153.50-1332-0.30%
2024/07/151148.501151.00150.5003370.00%
2024/07/111152.5000.00152.5013290.30%
2024/07/082.5154.7600.00154.002.53580.70%
2024/07/050.2160.5000.00161.000.23450.04%
2024/07/0400.001163.50161.50-1340-0.29%
2024/07/033.1162.652164.50162.001.13350.33%
2024/07/010.3157.0000.00157.000.32930.10%
2024/06/170156.5000.00158.0002740.00%
2024/04/2900.000145.50146.0004570.00%
2024/04/240145.5000.00145.5005000.00%
2024/04/150.1147.5400.00145.500.15730.02%
2024/04/0200.002157.00155.50-2576-0.35%
2024/03/290.1154.5000.00154.500.15830.02%
2024/03/2100.001153.00153.00-1616-0.16%
2024/03/2000.001153.50153.50-1625-0.16%
2024/03/180.2152.0000.00151.500.26490.03%
2024/03/152152.5000.00152.5026690.30%
2024/03/144152.250.1152.50152.503.96750.58%
2024/03/133154.505154.20153.50-2686-0.29%
2024/03/122153.0000.00152.5027020.28%
2024/03/072146.751149.50149.5018220.12%
2024/03/063152.671152.00152.0028590.24%
2024/03/051157.5000.00159.5018320.12%
2024/03/041.1157.0500.00157.501.18320.13%
2024/03/012158.2500.00158.5028350.24%
2024/02/270.1160.2500.00158.500.18320.01%
2024/02/230160.0000.00159.0008270.00%
2024/02/2200.000.3160.00160.00-0.3835-0.03%
2024/02/211162.0000.00162.5018280.12%
2024/02/1900.002160.75162.50-2834-0.24%
2024/02/162157.751159.50158.5018330.12%
2024/02/152.5157.5300.00159.502.58290.30%
大江基因轉投資亞洲準譯完成現增 引進啟新、永豐證創投Anue鉅亨-15天前
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
大江 相關文章